MJNA Medical Marijuana Inc

Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Featured in Reuters Discussing Future of Mexico’s Cannabis Industry

Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Featured in Reuters Discussing Future of Mexico’s Cannabis Industry
EN
08/10/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medical Marijuana Inc

 PRESS RELEASE

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on ...

Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion World’s First-Ever Publicly Traded Cannabis Company Appoints Longtime Board Member as New CEO SAN DIEGO, CA , March 14, 2023 (GLOBE NEWSWIRE) -- via – (OTC: MJNA) (the “Company”), a holding company with operating assets dedicated to the cannabis and hemp industries, along with portfolio investments in companies in the biotechnology industry, announced today the appointment of Dr. Timothy R. Scott as its new Chief Executive Officer, President, and Chairman of the Board. Dr. Scott takes ...

 PRESS RELEASE

Medical Marijuana, Inc. Participates in Preclinical Research Study on ...

Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries Study Carried Out by Center for Research and Advanced Studies of the IPN and the Siglo XXI National Medical Center Show Advantages of Oral Administration of CBD to Reduce Levels of Neuronal Death in Animal Model SAN DIEGO, CA, Feb. 06, 2023 (GLOBE NEWSWIRE) -- via –  (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply c...

 PRESS RELEASE

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New F...

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point New Products Offer 3,000mg to 6,000mg, Will Come in Jars of 30 and 60mL, Presenting Significant Cost Savings to Rapidly Growing Brazil Market SAN DIEGO, CA, Jan. 24, 2023 (GLOBE NEWSWIRE) -- via – (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary launched two new fu...

 PRESS RELEASE

Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team Wi...

Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology Direct Selling Subsidiary Taps Network Marketing Legends to Lead Communication and Information Technologies as Company Continues International Expansion SAN DIEGO, CA, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via – (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply ch...

 PRESS RELEASE

Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Th...

Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results SAN DIEGO, CA, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via – (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending September 30, 2022, and provided an overview of recent operational highlights. First Quarter 2022 Financial and Operational Highlights Generated $4.9 million...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch